erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Leukemia, Lymphoid D007945 18 associated lipids
Liver Cirrhosis, Alcoholic D008104 17 associated lipids
Cholelithiasis D002769 16 associated lipids
Choline Deficiency D002796 16 associated lipids
Blister D001768 16 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
HIV Seropositivity D006679 15 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
VELEZ MORAN C [Experience with erythromycin in the Hospital de Aislamiento de Guayaquil]. 1953 Rev Ecuat Hig Med Trop pmid:13237604
LEVADITI C et al. [Erythromycin; new antibiotic derived from Streptomyces erythreus]. 1953 Ann Inst Pasteur (Paris) pmid:13148738
PARIS J [Severe recurrent intestinal infection due to pathogenic Staphylococcus aureus treated with various antibiotics; favorable effect of erythromycin]. 1953 Arch Mal Appar Dig Mal Nutr pmid:13149270
[Erythromycin, a new antibiotic]. 1953 Dia Med pmid:13083424
KIRBY WM et al. Erythromycin serum concentrations following administration in acid-resistant tablets. 1953 Antibiot Chemother (Northfield) pmid:24542409
JONES PN et al. Use of antibiotics in nonbacterial respiratory infections. 1953 J Am Med Assoc pmid:13084382
KIRSHBAUM A et al. A cupplate method for the determination of erythromycin concentrations in serum and other body fluids. 1953 Antibiot Chemother (Northfield) pmid:24542421
ROMANSKY MJ Current trends in antibiotic therapy. 1953 Med Bull US Army Eur pmid:13085979
CLARK RK The chemistry of erythromycin. I. Acid degradation products. 1953 Antibiot Chemother (Northfield) pmid:24542535
FABRE J [A new antibiotic: erythromycin; its therapeutic effect in 60 cases of various diseases]. 1953 Praxis pmid:13088584
MAPLE FM et al. Serum concentrations of erythromycin following intravenous administration. 1953 Antibiot Chemother (Northfield) pmid:24542586
BUNN PA and COOK E Treatment of pneumococcal pneumonia with erythromycin and carbomycin (magnamycin). 1953 AMA Arch Intern Med pmid:13091455
LEE CC et al. Tissue distribution of erythromycin in rats. 1953 Antibiot Chemother (Northfield) pmid:24542649
KIRBY WM et al. Treatment of staphylococcic infections with erythromycin. 1953 AMA Arch Intern Med pmid:13091463
SYLVESTER JC and JOSSELYN LE Absorption of erythromycin. II. Erythromycin stearate. 1953 Antibiot Chemother (Northfield) pmid:24542651
BACON AE Erythromycin in the treatment of pneumococcal pneumonia. 1953 Del Med J pmid:13094978
HERRELL WE et al. Erythromycin for infections due to Micrococcus pyogenes. 1953 J Am Med Assoc pmid:13069224
ROBINSON HM and ZELIGMAN I Erythromycin ointment in the treatment of the pyodermas. 1953 J. Invest. Dermatol. pmid:13069824
ROBINSON HM and COHEN MM Treatment of granuloma inguinale with erythromycin. 1953 J. Invest. Dermatol. pmid:13069825
SUPNIEWSKI J [Erythromycin]. 1953 Pol Tyg Lek (Wars) pmid:13073602
MATHIEU DE FOSSEY B [A new antibiotic: erythromycin]. 1953 Presse Med pmid:13074126
FLIPPIN HF and FOLTZ EL The newer antimicrobial agents. 1953 Am Pract Dig Treat pmid:13080581
BAZAN C et al. [Treatment of whooping cough with erythromycin]. 1953 Rev Chil Pediatr pmid:13134787
BRICAIRE H and DE FOSSEY B [Two new antibiotics: erythromycin and soframycin]. 1953 Rev Prat pmid:13135190
LUND E [Erythromycin, a new antibiotic]. 1953 Ugeskr. Laeg. pmid:13136562
VANNUCCHI V [Ilotycin sulfa: association of ilotycin with a trisulfonamide]. 1953 Riv Crit Clin Med pmid:14358369
HAIGHT TH and FINLAND M The antibacterial action of erythromycin. 1952 Proc. Soc. Exp. Biol. Med. pmid:13047351
VANNUCCHI V [Clinical study of a new antibiotic; erythromycin]. 1952 Riv Crit Clin Med pmid:13056483
ERYTHROMYCIN. 1952 Br Med J pmid:12987755
ANDERSON RC et al. The toxicity and distribution of ilotycin. 1952 J Am Pharm Assoc Am Pharm Assoc pmid:12999613
ERYTHROMYCIN, new and promising antibiotic. 1952 N. Engl. J. Med. pmid:14947939
HAIGHT TH and FINLAND M Laboratory and clinical studies on erythromycin. 1952 N. Engl. J. Med. pmid:14947931
ERYTHROMYCIN: another antibiotic. 1952 Lancet pmid:14939901
pmid:5110814
Bottega A et al. Evaluation of constitutive and inducible resistance to clindamycin in clinical samples of Staphylococcus aureus from a tertiary hospital. Rev. Soc. Bras. Med. Trop. pmid:25467260
pmid:16888699
Zhou W et al. Erythromycin-resistant genes in group A β-haemolytic Streptococci in Chengdu, Southwestern China. Indian J Med Microbiol pmid:25008823
Abraham T and Sistla S Trends in antimicrobial resistance patterns of Group A streptococci, molecular basis and implications. Indian J Med Microbiol pmid:30084408
pmid:
Pranteda G et al. Pitted keratolysis, erythromycin, and hyperhidrosis. Dermatol Ther pmid:24703267
Wang X et al. Phenotypic and molecular characterization of Streptococcus agalactiae colonized in Chinese pregnant women: predominance of ST19/III and ST17/III. Res. Microbiol. pmid:29378338
Yayan J and Rasche K Growing Antibiotic Resistance in Fatal Cases of Staphylococcal Pneumonia in the Elderly. Adv. Exp. Med. Biol. pmid:26747068
Alvarez-Sánchez M et al. [Bacterial resistance in acne? A meta-analysis of the controversy]. Cir Cir pmid:26738649
Mondragón-Navarro M et al. Potential association between erythromycin and cholestatic hepatitis. Med Intensiva pmid:26707838
Thomas J et al. Residents'corner October 2015. DeRmpath&Clinic: Acute generalised exanthematous pustulosis. Eur J Dermatol pmid:26693641
Jahansepas A et al. Occurrence of Enterococcus faecalis and Enterococcus faecium in Various Clinical Infections: Detection of Their Drug Resistance and Virulence Determinants. Microb. Drug Resist. pmid:28525287
Silva V et al. Genetic Characterization of vanA-Enterococcus faecium Isolates from Wild Red-Legged Partridges in Portugal. Microb. Drug Resist. pmid:28504889
McCutcheon K and Manga P An antibiotic recipe for an arrhythmic disaster. Cardiovasc J Afr pmid:26592910
Commerford PJ From the Editor's Desk. Cardiovasc J Afr pmid:26592903
Fallahpour N et al. Overproduction of Erythromycin by Ultraviolet Mutagenesis and Expression of ermE Gene in Saccharopolyspora erythraea. Assay Drug Dev Technol pmid:29120674